Qube Research & Technologies LTD Amgen Inc Put Options Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $9 Million - $9.82 Million	-29,100 Reduced 8.22%	325,000 $105 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $32.8 Million - $39.9 Million	-124,900 Reduced 26.08%	354,100 $111 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $73.9 Million - $89.2 Million	274,800 Added 134.57%	479,000 $136 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $50.9 Million - $57.4 Million	199,100 Added 3903.92%	204,200 $58.8 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $3.59 Million - $4.45 Million	-16,400 Reduced 76.28%	5,100 $1.37 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $4.61 Million - $5.45 Million	21,500 New	21,500 $4.77 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.